Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.
作者信息
Meylan Sylvain, Livio Françoise, Foerster Maryline, Genoud Patrick James, Marguet François, Wuerzner Gregoire
机构信息
Department of Medicine, Infectious Diseases Service, University Hospital Lausanne and University of Lausanne, Switzerland (S.M.).
Service of Clinical Pharmacology, Department of Laboratories (F.L.), Lausanne University Hospital and University of Lausanne, Switzerland.
出版信息
Hypertension. 2021 Jun;77(6):e56-e57. doi: 10.1161/HYPERTENSIONAHA.121.17316. Epub 2021 Mar 25.
Abstract
摘要
相似文献
1
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.基于mRNA的SARS-CoV-2疫苗接种后患者的III期高血压
Hypertension. 2021 Jun;77(6):e56-e57. doi: 10.1161/HYPERTENSIONAHA.121.17316. Epub 2021 Mar 25.
2
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
3
Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.追踪新冠疫苗犹豫情绪及后勤挑战：一种机器学习方法。
PLoS One. 2021 Jun 2;16(6):e0252332. doi: 10.1371/journal.pone.0252332. eCollection 2021.
4
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
5
Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?2019冠状病毒病（COVID-19）疫苗接种后发生的自身免疫性肝炎：是因果关系还是偶然事件？
J Hepatol. 2021 Jul;75(1):222-224. doi: 10.1016/j.jhep.2021.04.003. Epub 2021 Apr 20.
6
Myocarditis After BNT162b2 and mRNA-1273 Vaccination.接种 BNT162b2 和 mRNA-1273 后心肌炎。
Circulation. 2021 Aug 10;144(6):506-508. doi: 10.1161/CIRCULATIONAHA.121.055913. Epub 2021 Jun 16.
7
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.多发性骨髓瘤患者两剂 SARS-CoV-2 信使 RNA 疫苗接种的安全性和抗体反应。
BMC Cancer. 2021 Dec 27;21(1):1354. doi: 10.1186/s12885-021-09097-5.
8
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.mRNA COVID-19 疫苗接种后发生急性心肌炎的患者。
JAMA Cardiol. 2021 Oct 1;6(10):1196-1201. doi: 10.1001/jamacardio.2021.2828.
9
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
10
Liver injury following SARS-CoV-2 vaccination: A multicenter case series.新型冠状病毒2型疫苗接种后的肝损伤：一项多中心病例系列研究。
J Hepatol. 2022 Jan;76(1):211-214. doi: 10.1016/j.jhep.2021.07.024. Epub 2021 Jul 31.
引用本文的文献
1
Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review.揭示新冠疫苗的心血管风险与益处：一项系统评价
Cardiovasc Toxicol. 2025 Feb;25(2):306-323. doi: 10.1007/s12012-024-09954-2. Epub 2025 Jan 18.
2
Safety pharmacology of human endogenous retrovirus-enveloped baculoviral DNA vaccines against SARS-CoV-2 in Sprague-Dawley rats and beagle dogs.人内源性逆转录病毒包膜杆状病毒DNA疫苗针对新型冠状病毒在斯普拉格-道利大鼠和比格犬中的安全性药理学研究
Vaccine X. 2024 Aug 3;20:100545. doi: 10.1016/j.jvacx.2024.100545. eCollection 2024 Oct.
3
Evaluation of blood pressure variation in recovered COVID-19 patients at one-year follow-up: a retrospective cohort study.恢复期 COVID-19 患者一年随访时血压变异性评估：一项回顾性队列研究。
BMC Cardiovasc Disord. 2024 May 7;24(1):240. doi: 10.1186/s12872-024-03916-w.
4
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac and ChAdOx1-S Vaccines for SARS-CoV-2.对于已接种 CoronaVac 和 ChAdOx1-S 新冠疫苗的成年人，半剂量异源 mRNA-1273 加强疫苗接种的免疫原性和安全性。
Vaccines (Basel). 2024 Mar 22;12(4):344. doi: 10.3390/vaccines12040344.
5
Genotoxicity and safety pharmacology of the rVSVInd(GML)-mspSGtc vaccine against SARS-CoV-2 in Sprague-Dawley rats and Beagle dogs.rVSVInd(GML)-mspSGtc 疫苗对 SARS-CoV-2 的遗传毒性和安全药理学在 Sprague-Dawley 大鼠和比格犬中的研究。
Arch Toxicol. 2024 Jul;98(7):2185-2197. doi: 10.1007/s00204-024-03746-x. Epub 2024 Apr 12.
6
Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study.探索接种新冠疫苗的阿拉伯人群中报告的疫苗不良反应：一项跨国调查研究。
Sci Rep. 2024 Feb 27;14(1):4785. doi: 10.1038/s41598-024-54886-0.
7
COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barré Syndrome, and mortality in South Korea using a nationwide population-based cohort study.COVID-19 疫苗安全性：使用全国基于人群的队列研究评估韩国过敏反应、心肌炎、心包炎、吉兰-巴雷综合征和死亡率的背景发病率。
PLoS One. 2024 Feb 21;19(2):e0297902. doi: 10.1371/journal.pone.0297902. eCollection 2024.
8
Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study.中国高血压患者对 COVID-19 加强针的接受情况：一项多中心横断面研究。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2283315. doi: 10.1080/21645515.2023.2283315. Epub 2023 Nov 20.
9
Increased blood pressure after nonsevere COVID-19.非重症 COVID-19 后血压升高。
J Hypertens. 2023 Nov 1;41(11):1721-1729. doi: 10.1097/HJH.0000000000003522. Epub 2023 Sep 13.
10
Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection.SARS-CoV-2 疫苗中病毒刺突的分子模拟可能会导致 ACE2 短暂失调，导致类似于 SARS-CoV-2 感染的血管和凝血功能障碍。
Viruses. 2023 Apr 25;15(5):1045. doi: 10.3390/v15051045.
本文引用的文献
1
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.
2
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
3
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
4
Prevalence and determinants of white coat effect in a large UK hypertension clinic population.英国一家大型高血压诊所人群中白大衣效应的患病率及其决定因素。
J Hum Hypertens. 2016 Jun;30(6):386-91. doi: 10.1038/jhh.2015.95. Epub 2015 Sep 17.
5
Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.未破裂颅内动脉瘤患者管理指南：美国心脏协会/美国卒中协会给医疗保健专业人员的指南
Stroke. 2015 Aug;46(8):2368-400. doi: 10.1161/STR.0000000000000070. Epub 2015 Jun 18.
Zotero 插件